Science and Technology
Source : (remove) : STAT
RSS • JSON • XML • CSV
Science and Technology
Source : (remove) : STAT
RSS • JSON • XML • CSV
Thu, June 5, 2025
[ Yesterday Afternoon ] - STAT
A cautious culture cost Novo its obesity lead
Sat, May 31, 2025
[ Last Saturday ] - STAT
Illumina's PromoterAI unlocks rare disease clues in noncoding genome
Thu, May 29, 2025
[ Thu, May 29th ] - STAT
Lilly to acquire biotech developing pain drugs
Wed, May 28, 2025
[ Wed, May 28th ] - STAT
VC Survey: The biggest impacts of AI on health care?
Sat, May 24, 2025
[ Sat, May 24th ] - STAT
CRISPR pioneer Prime Medicine switches CEO and lays off quarter of its staff
[ Sat, May 24th ] - STAT
GSK drug's new approval sets up competition with Dupixent
Fri, May 23, 2025
[ Fri, May 23rd ] - STAT
Medtronic plans to break off diabetes business
Wed, May 21, 2025
[ Wed, May 21st ] - STAT
When the FDA requires a large vaccine trial, who pays?
Mon, May 19, 2025
[ Mon, May 19th ] - STAT
Trump's science adviser calls for return to 'gold-standard' research to kickstart stalled advances
Tue, May 13, 2025
[ Tue, May 13th ] - STAT
Intellia cuts 27% of staff, in the latest wave of gene-editing layoffs
Sun, May 4, 2025
[ Sun, May 04th ] - STAT
At AACR, leading cancer researchers urge colleagues to 'fight for your science'
Tue, April 29, 2025
[ Tue, Apr 29th ] - STAT
STAT readers on the value of medical comedy, the pediatrician shortage, and more
Mon, April 28, 2025
[ Mon, Apr 28th ] - STAT
What would Hippocrates think of these First Opinions?
[ Mon, Apr 28th ] - STAT
Uniqure gets FDA OK to seek accelerated approval
Tue, April 22, 2025
[ Tue, Apr 22nd ] - STAT
Health AI startups: How long do they take to hit $10 million in sales
Wed, April 16, 2025
[ Wed, Apr 16th ] - STAT
J&J reports earnings beat as tariffs loom
Tue, April 15, 2025
[ Tue, Apr 15th ] - STAT
STAT readers on cadavers in med education, doctors and AI, and more
[ Tue, Apr 15th ] - STAT
Pfizer discontinues its experimental GLP-1 pill
Fri, March 28, 2025
[ Fri, Mar 28th ] - STAT
At meeting on guardrails for gene editing of human embryos, some call for a dead end
Wed, March 26, 2025
[ Wed, Mar 26th ] - STAT
Marty Makary and Jay Bhattacharya confirmed by Senate as FDA commissioner and NIH director
[ Wed, Mar 26th ] - STAT
Tara Schwetz, who oversaw creation of ARPA-H, placed on leave by NIH
Tue, March 25, 2025
[ Tue, Mar 25th ] - STAT
Trump picks Susan Monarez to run the CDC
Thu, March 13, 2025
[ Thu, Mar 13th ] - STAT
Federal research instability risks postdoc careers, American leadership
Fri, March 7, 2025
[ Fri, Mar 07th ] - STAT
At 'Stand Up for Science' rally, Francis Collins .. arns major NIH research programs 'at severe risk'
Thu, March 6, 2025
[ Thu, Mar 06th ] - STAT
A state-by-state breakdown of LGBTQ+ youth mental health
Mon, February 17, 2025
[ Mon, Feb 17th ] - STAT
At premier science gathering, 'anger, uncertainty .. anxiety' about the future of research under Trump
Fri, February 14, 2025
[ Fri, Feb 14th ] - STAT
Trump administration to fire thousands at health agencies
Fri, February 7, 2025
[ Fri, Feb 07th ] - STAT
Signs of life at the CDC
Tue, February 4, 2025
[ Tue, Feb 04th ] - STAT
Scoop: Sword teases AI mental health expansion
Tue, January 21, 2025
[ Tue, Jan 21st ] - STAT
Three former FDA officials: Here's what Trump and his nominees need to know

A cautious culture cost Novo its obesity lead


//science-technology.news-articles.net/content/2 .. cautious-culture-cost-novo-its-obesity-lead.html
Published in Science and Technology on by STAT   Print publication without navigation

And more biotech news updates, brought to you by The Readout.

The article from STAT News dated June 5, 2025, discusses several significant developments in the biotech industry. Novo Nordisk is set to acquire Vigil Neuroscience for $1.5 billion, aiming to bolster its neuroscience portfolio. Merck is facing challenges with its blockbuster cancer drug Keytruda, as a new study suggests it may not be as effective in certain patient populations as previously thought. Eli Lilly is expanding its manufacturing capabilities to meet the growing demand for its diabetes and obesity treatments. Lastly, REGENXBIO reported positive results from a Phase II trial of its gene therapy for Duchenne muscular dystrophy, sparking optimism about future treatments for the condition.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/06/05/biotech-news-novo-nordisk-vigil-merck-eli-lilly-regenxbio-keytruda-the-readout/ ]

Publication Contributing Sources